3rd Quarter - Report

MERCK & CO, INC. for MERCK & CO INC

Firm
Client
Income
—
Expenses
$1,420,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill).

LobbyistCovered position, as disclosed
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
KATIE OPPENHEIM New Legislative Ass't (Crapo) 10/06-12/10
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Manufacturing MAN

Supply chain safety (H.R. 1919, S. 959, S. 957)

LobbyistCovered position, as disclosed
ELI JOSEPH —
JEROME MURRAY —
KATIE OPPENHEIM New Legislative Ass't (Crapo) 10/06-12/10
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1919 (113th), S. 957 (113th), S. 959 (113th)

Trade (domestic/foreign) TRD

Trans-Pacific Partnership (no specific bill); biologic data exclusivity (no specific bill); US-EU trade agreement (no specific bill); trade promotion authority (no specific bill); treatment of intellectual property in India (no specific bill); additives in beef cattle (no specific bill); treatment of intellectual property in India

LobbyistCovered position, as disclosed
ELI JOSEPH —
JEROME MURRAY —
KATIE OPPENHEIM New Legislative Ass't (Crapo) 10/06-12/10
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Health Issues HCR

Alzheimer's education (no specific bill); 340b (no specific bill); maternal health education (no specific bill).

LobbyistCovered position, as disclosed
ELI JOSEPH —
ROBERT MCMAHON —
JEROME MURRAY —
KATIE OPPENHEIM New Legislative Ass't (Crapo) 10/06-12/10
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351)

LobbyistCovered position, as disclosed
ELI JOSEPH —
JEROME MURRAY —
KATIE OPPENHEIM New Legislative Ass't (Crapo) 10/06-12/10
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 351 (113th), S. 351 (113th)

Budget/Appropriations BUD

Deficit reduction (no specific bill); ADAP funding (no specific bill); Sequestration of FDA user fees (S. 1413, H.R.2775)

LobbyistCovered position, as disclosed
ELI JOSEPH —
JEROME MURRAY —
KATIE OPPENHEIM New Legislative Ass't (Crapo) 10/06-12/10
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Bills named: H.R. 2775 (113th), S. 1413 (113th)

Consumer Issues/Safety/Products CSP

Access to over-the-counter medications (no specific bill); compounding (no specific bill)

LobbyistCovered position, as disclosed
ELI JOSEPH —
JEROME MURRAY —
KATIE OPPENHEIM New Legislative Ass't (Crapo) 10/06-12/10
ERIN POLAK —
ANGELA M STEWART —
JASON BENJAMIN VAN PELT —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.